Last reviewed · How we verify
NCT06113978: MISforPPH
Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18
NA trial testing Thoracoscopic sympathectomy in Hyperhidrosis in 420 participants. Completed in 30 August 2023.
15 March 2023
Quick facts
| Lead sponsor | dr. Muhammad Abdelhafez Mahmoud, MD |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 420 |
| Start date | 1 September 2022 |
| Primary completion | 15 March 2023 |
| Estimated completion | 30 August 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Thoracoscopic sympathectomy
- Thoracoscopic sympathotomy
- Thoracoscopic sympathetic chain clipping
Conditions studied
- Hyperhidrosis — all drugs for Hyperhidrosis →
- Children, Adolescents — all drugs for Children, Adolescents →
- Thoracoscopic Sympathetic Chain Interruption — all drugs for Thoracoscopic Sympathetic Chain Interruption →
- Sympathetic Disorder — all drugs for Sympathetic Disorder →
Sponsor
dr. Muhammad Abdelhafez Mahmoud, MD
Who can join
Adults 6 to 14, any sex, with Hyperhidrosis or Children, Adolescents. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the investigators aim to present fifteen years' experience of thoracoscopic sympathetic chain interruption for primary palmar hyperhidrosis in children and adolescents; evaluation of 3 different techniques (sympathectomy, sympathotomy, and clipping) regarding demographic data, surgical outcomes, complications, compensatory sweating, and patients' satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06113978
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperhidrosis
Currently open trials in the same condition.
- NCT05805696 — Treatment and Mapping of Impostor Phenomenon · NA · recruiting
- NCT05102396 — Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? · Phase 2 · recruiting
- NCT05403710 — Botulinum Toxin Therapy in Hidradenitis Suppurativa · recruiting
Other dr. Muhammad Abdelhafez Mahmoud, MD trials
Trials by the same sponsor.
- NCT05957562 — Azygos Vein Preservation; Its Impact on Early Outcomes After Neonatal EA/TOF Repair · NA · completed
- NCT04990570 — Telemedicine (Virtual Clinic) for Pediatric Surgery During Covid-19 Pandemic · completed
- NCT05144659 — Evaluation of Double Faced Transverse Preputial Onlay Island Flap for Hypospadias Repair in Pediatrics · NA · completed
- NCT04821167 — Safety and Efficiency of Laparoscopic Management of Intra-canalicular (Emergent) Testis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06113978 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by dr. Muhammad Abdelhafez Mahmoud, MD
- Last refreshed: 2 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06113978.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing